23rd Edition Strategic Project & Portfolio Management for Pharma Conference
25-27 January, 2023 | Barcelona, Spain
Taking advantage of new opportunities, technologies and organisational models to accelerate project portfolio delivery
With ongoing and ever tightened budget cuts, pharma companies are struggling to prioritise projects with limited R&D budget – whilst at the same time the patent cliff is drying up the product pipeline which will have immense aftermaths of the company’s revenue stream. Pharma companies are now dedicating more efforts to have systematic and rigorous approach to portfolio management, by reinforcing both analytical and organisational skills, to have strong decision analysis processes as well as performing teams to handle them. From one side, they need to generate data, assess realistic scenarios of value and risks, make necessary decisions under great deal of uncertainty, have a flexible approach and set parameters to benchmark and rank projects, as well as optimise resource allocation and minimise expenditure. On the other hand, it’s crucial to have organisational culture to underline technique, develop a performing capacity management and foster decisions based on an agile mindset.
With this in mind, the marcus evans 23rd Edition Strategic Project & Portfolio Management for Pharma conference taking place on 25-27 January, 2023 in Barcelona, Spain, will bring together leading project and portfolio managers to discuss how they’re supporting critical decision-making capabilities through implementing the best methodologies, technologies, and organizational models. The event will explore how you can maximize the value and resilience of your portfolio through the best practices in project prioritization and resource allocation, focusing on creating the ideal balance between risks and opportunities. All these topics and more will be discussed in an open and engaging environment, with plenty of networking and brainstorming during the interactive sessions. At the end you’ll walk away with actionable insights on how to build effective management capabilities and navigate critical decisions.
Attending This Premier marcus evans Conference Will Enable You to:
- Articulate your priorities better in an uncertain environment
- Balance financial & scientific value to ensure project & portfolio alignment with strategic goals
- Explore the impact of data analytics, AI and machine learning applied to R&D portfolio management
- Maximise portfolio value under limited budget
- Explore how to manage capacities and prioritise between projects
- Align R&D with Commercial with an integrated data strategy between projects
- Manage innovation and risk in the early pipeline
Best Practices and Case Studies from:
- Tom Halliwell, Senior Vice President & Head of Operations, Ariceum Therapeutics, United Kingdom
- Gilles Brackman, Vice President R&D, Flen Health, Belgium
- Simone Frandsen, Director R&D Portfolio and Strategy, LEO Pharma, Denmark
- Thorsten Knoechel, Head of R&D Governance Operations, Merck, Germany
- Thomas Benedetto, Executive Director, R&D Capabilities, Bristol Meyers Squibb, United States
- Heidi Peachey, Portfolio Manager, Cancer Research UK, United Kingdom
PIPMG members are entitled to €200 discount! For more information please contact: Ria Kiayia, Digital Media and PR Marketing Executive at riak@marcusevanscy.com or visit: https://bit.ly/3CuX0nG